Key questions and answers about pregnancy-associated plasma protein-A

Trends in Endocrinology and Metabolism

Volumn 23, Issue 5, 2012, Pages 242-249

  Conover, Cheryl A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN;

CELL TYPE; CLINICAL ASSESSMENT; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

FEMALE; HUMANS; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; SOMATOMEDINS;

EID: 84860377296     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.02.008     Document Type: Review

References (91)

1. Lin T.M., et al. Characterization of four human pregnancy-associated plasma proteins. Am. J. Obstet. Gynecol. 1974, 118:223-236.
2. Folkersen J., et al. Pregnancy-associated plasma protein-A: circulating levels during normal pregnancy. Am. J. Obstet. Gynecol. 1981, 139:910-914.
3. Wald N.J., et al. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N. Engl. J. Med. 1999, 341:461-467.
4. Brizot M.L., et al. Gene expression of human pregnancy-associated plasma protein-A in placenta from trisomic pregnancies. Placenta 1996, 17:33-36.
5. Smith G.C.S., et al. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J. Clin. Endocrinol. Metab. 2002, 87:1762-1767.
6. Poon L.C.Y., et al. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet. Gynecol. 2009, 33:23-33.
7. Smith G.C.S., et al. Early-pregnancy origins of low birth weight. Nature 2002, 417:916.
8. Boldt H.B., Conover C.A. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. Growth Horm. IGF Res. 2007, 17:10-18.
9. Qin X., et al. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. Arch. Biochem. Biophys. 2000, 379:209-216.
10. Laursen L.S., et al. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 2001, 504:36-40.
11. Lawrence J.B., et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:3149-3153.
12. Conover C.A., et al. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 2004, 131:1187-1194.
13. Stocker W., et al. The metzincins: topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 1995, 4:823-840.
14. Boldt H.B., et al. Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin. Biochem. J. 2001, 358:359-367.
15. Overgaard M.T., et al. Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J. Biol. Chem. 2001, 276:21849-21853.
16. Yan X., et al. Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability. J. Clin. Endocrinol. Metab. 2010, 95:1412-1420.
17. Christians J.R., et al. PAPPA2, an enzyme that cleaves an insulin-like growth-factor-binding protein, is a candidate gene for a quantitative trait locus affecting body size in mice. Genetics 2006, 173:1547-1553.
18. Conover C.A., et al. Pregnancy-associated plasma protein A2 (PAPP-A2): tissue expression and biological consequences of gene knock-out in mice. Endocrinology 2011, 152:2837-2844.
19. Oxvig C., et al. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J. Biol. Chem. 1993, 268:12243-12246.
20. Qin Q.-P., et al. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy. Clin. Chem. 2005, 51:75-83.
21. Resch Z.T., et al. Pregnancy-associated plasma protein A gene expression as a target of inflammatory cytokines. Endocrinology 2004, 145:1124-1129.
22. Conover C.A., et al. Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol. Am. J. Physiol. Cell Physiol. 2006, 290:C183-C188.
23. Conover C.A., et al. Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells. Growth Horm. IGF Res. 2008, 18:213-220.
24. Conover C.A., et al. Regulation of pregnancy-associated plasma protein-A expression in cultured human osteoblasts. Bone 2004, 34:297-302.
25. Muhl H., Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int. Immunopharmacol. 2003, 3:1247-1255.
26. Chen B.-K., et al. Localization and regulation of pregnancy-associated plasma protein A expression in healing human skin. J. Clin. Endocrinol. Metab. 2003, 88:4465-4471.
27. Bayes-Genis A., et al. Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler. Thromb. Vasc. Biol. 2001, 21:335-341.
28. Resch Z.T., et al. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury. Endocrinology 2006, 147:5634-5640.
29. Rehage M., et al. Transgenic overexpression of pregnancy-associated plasma protein-A increases the somatic growth and skeletal muscle mass in mice. Endocrinology 2007, 148:6176-6185.
30. Bayes-Genis A., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N. Engl. J. Med. 2001, 345:1022-1029.
31. Sangiorgi G., et al. Pregnancy-associated plasma protein-A is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques. J. Am. Coll. Cardiol. 2006, 47:2201-2211.
32. Harrington S.C., et al. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ. Res. 2007, 100:1696-1702.
33. Gruber H.E., et al. The relationship between pregnancy-associated plasma protein-A (PAPP-A) and human intervertebral disc generation. Histol. Histopathol. 2010, 25:1431-1436.
34. Jadlowiec J., et al. Pregnancy-associated plasma protein-A is involved in matrix mineralization of human adult mesenchymal stem cells and angiogenesis in the chick chorioallontoic membrane. Endocrinology 2005, 146:3765-3772.
35. Sudo N., et al. Insulin-like growth factor-I (IGF-I) system during follicle development in the bovine ovary: relationship among IGF-I, type 1 IGF receptor (IGFR-1) and pregnancy-associated plasma protein-A (PAPP-A). Mol. Cell. Endocrinol. 2007, 264:197-203.
36. Aad P.Y., et al. Real-time RT-PCR quantification of pregnancy-associated plasma protein-A mRNA abundance in bovine granulosa and theca cells: effects of hormones in vitro. Domest. Anim. Endocrinol. 2006, 31:357-372.
37. Ortiz C.O., et al. Transforming growth factor-β regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts. J. Bone Miner. Res. 2003, 18:1066-1072.
38. Durham S.K., et al. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology. J. Bone Miner. Res. 1994, 9:111-117.
39. Resch Z.T., et al. Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibroblasts. Endocrinology 2006, 147:885-890.
40. Chandler H., et al. Skp2B overexpression alters a prohibitin-53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4. PloS ONE 2011, 6:1-10.
41. Hulsmans M., et al. MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J. 2011, 25:2515-2527.
42. Byun D., et al. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. J. Clin. Endocrinol. Metab. 2001, 86:847-854.
43. Qin X., et al. Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo. Endocrinology 2006, 147:5653-5661.
44. Phang D., et al. Inactivation of insulin-like-growth factors diminished the anabolic effects of pregnancy-associated plasma protein-A (PAPP-A) on bone in mice. Growth Horm. IGF Res. 2010, 20:192-200.
45. Ryan A.J., et al. Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumor growth in a murine model of breast cancer. Br. J. Cancer 2009, 101:278-286.
46. Conover C.A., et al. Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H284-H291.
47. Williams G.C. Pleiotrophy, natural selection, and the evolution of senescence. Evolution 1957, 11:398-411.
48. Bale L.K., Conover C.A. Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancy-associated plasma protein-A. J. Endocrinol. 2005, 186:325-331.
49. Nyegaard M., et al. Lack of functional pregnancy-associated plasma protein-A (PAPP-A) compromises mouse ovarian steroidogenesis and female fertility. Biol. Reprod. 2010, 82:1129-1138.
50. Mason E.J., et al. Insulin-like growth factor (IGF)-I and IGF-II contribute differentially to the phenotype of pregnancy-associated plasma protein-A knock-out mice. Growth Horm. IGF Res. 2011, 21:243-247.
51. Ning Y., et al. Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo. Mol. Endocrinol. 2008, 22:1213-1225.
52. Vallejo A.N., et al. Resistance to age-dependent thymic atrophy in long-lived mice that are deficient in pregnancy-associated plasma protein A. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:11252-11257.
53. Conover C.A., et al. Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A. J. Gerontol: Biol. Sci. 2010, 65:590-599.
54. Conover C.A., et al. Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A. J. Clin. Endocrinol. Metab. 1999, 84:4742-4745.
55. Mazerbourg S., et al. Pregnancy-associated plasma protein-A (PAPP-A) in ovine, bovine, porcine, and equine ovarian follicles: involvement in IGF binding protein-4 proteolytic degradation and mRNA expression during follicular development. Endocrinology 2001, 142:5243-5253.
56. Hourvitz A., et al. The regulated expression of the pregnancy-associated plasma protein-A in the rodent ovary: a proposed role in the development of dominant follicles and of corpora lutea. Endocrinology 2002, 143:1833-1844.
57. Juengel J.L., et al. The role of IGFs in the regulation of ovarian follicular growth in the bushtail possum (Trichosurus vulpecula). Reproduction 2010, 140:295-303.
58. Conover C.A., et al. Pregnancy-associated plasma protein-A is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum. Endocrinology 2001, 142:2155-2158.
59. Mazerbourg S., et al. The insulin-like growth factor system: a key determinant role in the growth and selection of ovarian follicles? A comparative species study. Reprod. Domest. Anim. 2003, 38:247-258.
60. Spicer L.J. Proteolytic degradation of insulin-like growth factor binding proteins by ovarian follicles: a control mechanism for selection of dominant follicles. Biol. Reprod. 2004, 70:1223-1230.
61. Laursen L.S., et al. Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. J. Biol. Chem. 2002, 277:47225-47234.
62. Weyer K., et al. Cell surface adhesion of pregnancy-associated plasma protein-A is mediated by four clusters of basic residues located in its third and fourth CCP module. Eur. J. Biochem. 2004, 271:1525-1535.
63. Conover C.A., et al. Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H994-H1000.
64. Laursen L.S., et al. Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein-4 and -5. Mol. Endocrinol. 2007, 21:1246-1257.
65. Swindell W.R., et al. In vivo analysis of gene expression in long-lived mice lacking the pregnancy-associated plasma protein A (PappA) gene. Exp. Gerontol. 2010, 45:366-374.
66. Tanner S.J., et al. Impact of pregnancy-associated plasma protein-A deletion on the adult murine skeleton. J. Bone Miner. Res. 2008, 23:655-662.
67. Kumar A., et al. Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism. J. Biol. Chem. 2005, 280:37782-37789.
68. Monget P., et al. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation. Biol. Reprod. 2003, 68:77-86.
69. Conover C.A. A unique receptor-independent mechanism by which insulin-like growth factor I regulates the availability of insulin-like growth factor binding proteins in normal and transformed human fibroblasts. J. Clin. Invest. 1991, 88:1354-1361.
70. Laursen L.S., et al. Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis. Biochem. J. 2002, 367:31-40.
71. Weyer K., et al. A substrate specificity-determining unit of three Lin12-Notch repeat modules is formed in trans within the pappalysin-1 dimer and requires a sequence stretch C-terminal to the third module. J. Biol. Chem. 2007, 282:10988-10999.
72. Boldt H.B., Conover C.A. Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo. Endocrinology 2011, 152:1470-1478.
73. Zhu W., et al. IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. Nature 2008, 454:345-349.
74. Miller B.S., et al. Pregnancy associated plasma protein-A is necessary for expeditious fracture healing in mice. J. Endocrinol. 2007, 192:505-513.
75. Li X., et al. PAPP-A: a possible pathogenic link to the instability of atherosclerotic plaque. Med. Hypotheses 2007, 70:597-599.
76. Crea F., Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend, or foe?. Eur. Heart J. 2005, 26:2075-2076.
77. Andreotti F., et al. Role of PAPP-A in atherothrombosis: messages to take home. Atherosclerosis 2009, 203:353-354.
78. Bulut I., et al. Relationship between pregnancy-associated plasma protein-A and lung cancer. Am. J. Med. Sci. 2009, 337:241-244.
79. Alexiadis M., et al. Insulin-like growth factor, insulin-like growth factor-binding protein-4, and pregnancy-associated plasma protein-A gene expression in human granulosa cell tumors. Int. J. Gynecol. Cancer 2006, 16:1973-1979.
80. See R., et al. Expression of recombinant murine pregnancy-associated plasma protein-A (PAPP-A) and a novel variant (PAPP-Ai) with differential proteolytic activity. Eur. J. Biochem. 2002, 269:2247-2256.
81. Iversen K., et al. Pregnancy associated plasma protein-A (PAPP-A) is not a marker of the vulnerable atherosclerotic plaque. Clin. Biochem. 2011, 44:312-318.
82. Lund J., et al. Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003, 108:1924-1926.
83. Elseber A.A., et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur. Heart J. 2006, 27:1678-1684.
84. Qin Q.-P., et al. Measurement and clinical significance of circulating PAPP-A in ACS patients. Clin. Chim. Acta 2007, 380:59-67.
85. Consuegra-Sanchez L., et al. Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atnerosclerosis 2009, 203:346-352.
86. Iversen K.K., et al. Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial. Atherosclerosis 2011, 214:203-208.
87. Tchkonia T., et al. Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R1286-R1296.
88. Tchoukalova Y.D., et al. Regional variation in adipogenesis and IGF regulatory proteins in the fetal baboon. Biochem. Biophys. Res. Commun. 2009, 380:679-683.
89. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 2000, 21:697-738.
90. Jensen M.D. Role of body fat distribution and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 2008, 93:557-563.
91. Qin X., et al. Differential regulation of pregnancy associated plasma protein (PAPP)-A during pregnancy in human and mouse. Growth Horm. IGF Res. 2002, 12:359-366.